SolutionHealth and Acadia Healthcare Form Joint Venture to Build a Behavioral Health Hospital in Southeast New Hampshire
This project will also be supported by $15 million in state funding from the New Hampshire Department of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Jul 23
This project will also be supported by $15 million in state funding from the New Hampshire Department of…
03 Jul 23
Cyltezo is the only adalimumab biosimilar with Phase III comparative clinical studies in rheumatoid arthritis, plaque psoriasis and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Jun 23
Under the NEURii collaboration, partners will pool their expertise in therapeutics, technology development and commercialisation, health data management…
30 Jun 23
According to the results, a single priming dose of Imjudo added to Imfinzi, called the STRIDE regimen, reduced…
30 Jun 23
The FDA approval was based on findings from the global Phase 3 GENEr8-1 study in which the annualised…
30 Jun 23
Lilly will purchase all the outstanding shares of Sigilon at a price of $14.92 per share, which amounts…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Jun 23
Two Revvity CE marked tests are recommended in latest version of NICE guidance “PLGF-based testing to help diagnose…
30 Jun 23
Global leader in post-harvest freshness solutions builds its advisory board.
30 Jun 23
PepsiCo is the first CPG company to collaborate with Stanford HAI's Affiliates Program and will contribute to its…
30 Jun 23
Bionano’s Stratys system for OGM offers increased throughput capabilities to address the needs of mid and high-volume users